Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

ENZN 0.930 +0.004 (0.42%)
price chart
Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for August 13, 2015
will begin trading ex-dividend on August 13, 2015. A cash dividend payment of $0.5 per share is scheduled to be paid on August 12, 2015.
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)
Compared to other companies in the Biotechnology industry and the overall market, ENZON PHARMACEUTICALS INC's return on equity significantly exceeds that of both the industry average and the S&P 500.
Enzon Pharmaceuticals Inc Plans Special Dividend of $0.50 (ENZN)
Enzon Pharmaceuticals logo Enzon Pharmaceuticals (NASDAQ:ENZN) declared a special dividend on Tuesday, July 7th, MarketBeat.
3 Sizzling Hot Biotech Stocks - Enzon Pharmaceuticals Inc (NASDAQ:ENZN ...  Wall Street Observer
Company Shares of Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) Drops by -5.04%
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) has lost 5.04% during the past week and dropped 6.9% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 6.01%.
Company Shares of Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) Rally 0.98%
Shares of Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) appreciated by 0.98% during the past week but lost 8.85% on a 4-week basis.
Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock
Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of ...
Biotechnology Stocks Technical Study -- Exelixis, XOMA Corp., Enzon Pharma ...
Over the previous three months and since the start of this year, Enzon Pharmaceuticals Inc.'s shares have surged 18.33% and 50.74%, respectively.
Company Shares of Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) Drops by -0.99%
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) has lost 0.99% during the past week and dropped 4.76% in the last 4 weeks.
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) Still on Royalty-Driven Autopilot
Enzon Pharmaceuticals Inc (NASDAQ:ENZN, ENZN message board) published a 10-Q report for the quarter ended Mar. 31, 2015 last week, only a few weeks after ENZN hit a 52-week high on the charts, became overbought and subsided again.
Biotech Stocks You Should Dump: Enzon Pharmaceuticals Inc (NASDAQ:ENZN), RXi ...
On the trading floor, shares of Enzon Pharmaceuticals Inc (NASDAQ:ENZN) dropped 1.77% to close at $1.11. The $49.93M company on August 7, 2015 said that “We receive royalty revenues from existing licensing arrangements with other companies ...